Clinical Trial Update: The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

View source ↗

Summary

This is a clinical trial update describing the LINFU U.S. Registry for patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Enrollment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraductal Papillary Mucinous Neoplasm of the Pancreas
• Pancreatic Adenocarcinoma
• Pancreatic Cysts

Snippet

Sponsor: Adenocyte, LLC | Conditions: IPMN, Pancreatic, Pancreas Cancer | Status: ENROLLING_BY_INVITATION